NL-OMON51566尚未招募不适用
FLowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) - FLASH study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Age >= 18 years
- •2. Clinical signs and symptoms consistent with acute pulmonary embolism (PE)
- •3. Echo, CTPA, or pulmonary angiographic evidence of proximal filling defect in
- •at least one main or lobar pulmonary artery
- •4. Scheduled for PE treatment with the FlowTriever System per the
- •Investigator*s discretion
排除标准
- •1. Unable to anticoagulate with heparin or alternative
- •2. Diagnosed with a minor PE with less than a 0.9 RV/LV ratio
- •3. Known sensitivity to radiographic contrast agents that, in the
- •Investigator*s opinion, cannot be adequately pre-treated
- •4. Imaging evidence or other evidence that suggests, in the opinion of the
- •Investigator, the patient is not appropriate for mechanical thrombectomy
- •intervention (e.g., inability to navigate to target location or predominately
- •chronic clot)
- •5. Life expectancy < 30 days, as determined by the Investigator
- •6. Current participation in another investigational drug or device treatment
- •study that, in the investigator*s opinion, would interfere with participation
- •in this study
研究者
相似试验
尚未招募
4 期
Post marketing study to evaluate the safety and performance of Everpro Everolimus-Eluting Coronary Stent System (EES) in all-comer patients with coronary artery disease (CAD) in routine clinical practiceCTRI/2020/07/026564Sahajanand Laser Technology Ltd
进行中（未招募）
不适用
A Multicenter, Patient-Masked, Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery SystemPatients who participated in a previous intravitreal Brimo PS DDS study, including 190342-028D (Retinitis pigmentosa) and 190342-032D (Geographic Atrophy from Age-related Macular Degeneration).EUCTR2010-019079-32-PTAllergan Limited290
进行中（未招募）
1 期
A Multicenter, Patient-Masked, Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery SystemPatients who participated in a previous intravitreal Brimo PS DDS study, including 190342-031D (Rhegmatogenous Macula-off Retinal Detachment).EUCTR2010-019079-32-GBAllergan Limited215
进行中（未招募）
不适用
A Multicenter, Patient-Masked, Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery SystemPatients who participated in a previous intravitreal Brimo PS DDS study, including 190342-036 (Subjects undergoing pars plana vitrectomy for posterior segment diseases)EUCTR2010-019079-32-CZAllergan Limited300
进行中（未招募）
不适用
A Multicenter, Patient-Masked, Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery SystemEUCTR2010-019079-32-DEAllergan Limited290